REPL
Replimune Group, Inc.NASDAQHealthcare$8.41+10.51%ClosedMarket Cap: $694.4M
As of 2026-04-06
Insider Statistics (Q1 2026)
Purchases
0
Sales
1
Buy/Sell Ratio
0.00
Total Bought
$0.00
Total Sold
$0.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Fri Feb 20 | Astley-Sparke Philip | director | Sell | 25,000 | $0.00 | 1,380,071 |
| Fri Dec 19 | Patel Sushil | director, officer: Chief Executive Officer | Sell | 200,000 | $0.00 | 533,576 |
| Fri Dec 19 | Xynos Konstantinos | officer: Chief Medical Officer | Sell | 60,000 | $0.00 | 199,685 |
| Fri Dec 19 | Hill Emily Luisa | officer: Chief Financial Officer | Sell | 60,000 | $0.00 | 194,368 |
| Fri Dec 19 | Sarchi Christopher | officer: Chief Commercial Officer | Sell | 35,000 | $0.00 | 158,088 |
| Fri Dec 19 | Schwendenman Andrew | officer: Chief Accounting Officer | Sell | 10,000 | $0.00 | 78,284 |
| Thu Dec 11 | Dhingra Kapil | director | Sell | 3,169 | $1.75 | 3,169 |
| Thu Dec 11 | Dhingra Kapil | director | Sell | 3,169 | $10.40 | 0 |
| Thu Dec 04 | Patel Sushil | director, officer: Chief Executive Officer | Sell | 10,000 | $11.13 | 333,576 |